Résumé
As a seasoned executive with over 30 years of global experience in healthcare, I currently serve as Global Healthcare Senior Advisor, providing strategic guidance and high-level expertise to senior leaders and decision-makers. Drawing on my extensive background as Executive Director in both large for-profit organizations and social entrepreneurship/philanthropy-driven divisions, I deliver actionable insights that drive innovation and positive change.
I have spearheaded international drug development and registration projects, including acceleration strategies such as WHO prequalification, orphan drugs, and early access programs. My leadership has also extended to critical access-to-care initiatives across malaria, pediatric oncology, maternal health, and vulnerable populations facing crises, homelessness, and migration.
In addition to my global work, I contribute as a member of the French Academy of Pharmacy, advising on key pharmaceutical issues through evidence-based recommendations.
As a non-executive leader, I bring a wealth of governance experience, having served as General Delegate, General Secretary, board member, and President. My strategic acumen, combined with a deep understanding of Corporate Social Responsibility (CSR), enables me to provide comprehensive, cross-functional expertise to boards of directors, grounded in both international experience and a strong sense of purpose.
I have successfully led initiatives addressing critical issues such as gender equality, social inclusion for refugees and migrants, climate change adaptation (emerging diseases), and the circular economy. My leadership is marked by a collaborative approach, bold decision-making, and a steadfast commitment to driving meaningful impact.
Currently, I serve as a board member of a clinical-stage biopharmaceutical company, contributing to its strategic direction and governance, particularly in the areas of ESG. In addition, as Chairwoman of RSE & Development, a non-profit organization dedicated to promoting CSR across Africa, I leverage my global expertise to drive sustainable and socially responsible growth.
Expériences professionnelles
Présidente - fondatrice
SMASH by V FAILLAT , -
Depuis le 17 avril 2024
SMASH by V FAILLAT est une société d’expertise et de conseil spécialisée dans la santé, utilisant une approche collective, holistique et intégrée.
Regulatory science and access senior advisor
Drug for Neglected Diseases initiative (DNDi) , Geneva
De Février 2022 à Mars 2024
Mécénat de compétences
Provided strategic regulatory guidance to accelerate drug development and access in Low- and Middle-income countries (LMICs)
Opportunities and challenges of Early Access Programme applied to neglected diseases new drugs in Low- and Middle-Income countries : Regulatory Perspectives
Benefit and challenges of reliance mechanisms based on the analysis of the new treatments delivered by DNDi : Change in regulatory reliance paradigm for a better access to innovative medicines in LMIC
Evaluated new strategic R&D pillars (one pillar under exploratory phase, the other one under feasibility phase) : Regulatory and access pre-assessment
Executive director of sanofi espoir foundation / former malaria programme director
SANOFI , Paris
De Avril 2017 à Décembre 2021
Led the transformation of the Foundation from traditional philanthropy to Venture Philanthropy, integrating impact measurement and ethical governance (Budget 6-9M€/year, 5-12 people)
Malaria programme director
SANOFI
De Avril 2015 à Avril 2017
Designated and implemented a social impact business model for malaria treatments (Budget 2M€/year, 7 people)
Regulatory affairs senior director
SANOFI AVENTIS GROUPE , Gentilly
De Avril 2005 à Mars 2017
Led regulatory strategy to improve access to medicines in Low- and Middle Income countries (Budget 2.5M€/year, 4 people)
Regulatory affairs manager
AVENTIS PHARMA , Paris
De Janvier 1989 à Mars 2005
Regulatory strategy and operations
Qualified Person - Pharmacien responsable Intérimaire (1991-2005)
Formations complémentaires
DOCTORAT
Université de Montpellier - Pharmacie
1983 à 1989
Certificat Administrateur de sociétés
Sciences Po
2023 à 2023
European Board Diploma
ecoDa - Climate & biodiversity
2024 à 2024
This programme, designed for European Board members, offers an extensive update on Need-to-Know European Corporate Governance topics and a strong focus on European bestpractices, board dynamics and soft skills.
Certificat Water Leadership Programme
Mines Paris - PSL Executive Education - Cycle de l'eau
2025 à 2026
Ce certificat atteste que son titulaire a complété avec succès le parcours Water Leadership Program. Il reconnait
l'acquisition de compétences fondamentales dans la compréhension approfondie du cycle de l'eau. Il valide des compétences transversales essentielles pour relever les défis de la transition écologique et climatique
Associations
Académie Nationale de Pharmacie
Secrétaire Commission Information Communication, GT écoconception, GT Obésité
Parcours officiels
Langues
Allemand - Notions
Arabe - Notions
Anglais - Courant
Français - Langue maternelle